The brightening power comes from a targeted blend of vitamin C, niacinamide, and glutathione
After reviewing this study, Anton Bilchik, MD, PhD, surgical oncologist, chief of medicine, and director of the Gastrointestinal and Hepatobiliary Program at Providence Saint Johns Cancer Institute in Santa Monica, CA, not involved in the research, told MNT this was one of the most provocative, interesting studies he has seen in a long time simply because there has been an explosion of interest and use of GLP-1 agonist drugs such as Ozempic and Mounjaro
Given that GLP-1 receptor agonists produce significant weight reduction typically 515% of body weight in clinical trials, with results varying by medication, dosage and individual responsethere is theoretical interest in whether these medications might indirectly improve vasomotor symptoms through weight loss
In September 2023, the FDA-approved Ozempic label was updated to include ileus, a condition where the intestines may stop moving waste normally
GLP-receptor agonists are medications that How do GLP-1 medications work to treat OSA
